SSA
CELG

Schonfeld Strategic Advisors’s Celgene Corp CELG Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-455,486
Closed -$45.2M – 1584
2019
Q3 		$45.2M Buy
455,486
+430,853
+1,749% +$40.9M 1.33% 6
2019
Q2 		$2.28M Buy
24,633
+5,433
+28% +$516K 0.08% 267
2019
Q1 		$1.81M Sell
19,200
-163,900
-90% -$14.3M 0.06% 365
2018
Q4 		$11.7M Buy
183,100
+165,700
+952% +$12.2M 0.45% 44
2018
Q3 		$1.56M Sell
17,400
-66,240
-79% -$5.85M 0.07% 337
2018
Q2 		$6.64M Buy
+83,640
New +$6.94M 0.36% 77
2017
Q3 		– Sell
-2,499
Closed -$325K – 882
2017
Q2 		$325K Buy
+2,499
New +$306K 0.03% 460
2017
Q1 		– Sell
-20,000
Closed -$2.31M – 835
2016
Q4 		$2.31M Sell
20,000
-341
-2% -$38K 0.3% 95
2016
Q3 		$2.13M Buy
20,341
+144
+0.7% +$15.6K 0.36% 69
2016
Q2 		$1.99M Sell
20,197
-5,116
-20% -$529K 0.45% 51
2016
Q1 		$2.53M Buy
+25,313
New +$2.61M 1.03% 17

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Schonfeld Strategic Advisors's CELG Position: Q4 2019 in Review

Schonfeld Strategic Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 455,486 shares — an estimated $45.2M sold.

Schonfeld Strategic Advisors first reported a position in CELG in Q1 2016 and held it in 11 quarters. The position peaked at $45.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Schonfeld Strategic Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 455,486 Celgene Corp shares in Q4 2019, an estimated $45.2M.
  • Schonfeld Strategic Advisors first reported a position in Celgene Corp in Q1 2016 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Celgene Corp position peaked at $45.2M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.